Please assess the completion status of the following clinical trial:

Trial Title: The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with Familial Mediterranean Fever according to Yalcinkaya or~* Tel-Hashomer criteria~* Diagnosis confirmed with the genetic analysis as compound heterozygote or~* homozygote mutation~* Patients between ages of 5-16 and weighted 15-30 kg~* Not received any treatment for FMF~Exclusion criteria:~* Major congenital malformation~* Organ transplantation~* Hepatic disorder~* Chronic kidney disease~* AA amyloidosis~* Thyroid disease~* Rheumatologic disorders other than FMF

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- once daily dosage schema of colchicine (Type: EXPERIMENTAL): The once daily dosage group was prescribed as once daily at 08:00 a.m. (Total 1mg)
- twice daily dosage schema of colchicine (Type: EXPERIMENTAL): Twice daily dosage group received the treatment twice daily at 08:00 a.m. and 08:00 p.m. (Total 1mg)

Based on this trial design, predict the completion outcome and termination type (if applicable).